Mihalcea Diana J, Florescu Maria, Suran Berenice M C, Enescu Oana A, Mincu Raluca I, Magda Stefania, Patrascu Natalia, Vinereanu Dragos
University and Emergency Hospital, Splaiul Independentei 169, 050098, Bucharest, Romania.
University of Medicine and Pharmacy Carol Davila, Splaiul Independentei 169, 050098, Bucharest, Romania.
Heart Vessels. 2016 Apr;31(4):568-77. doi: 10.1007/s00380-015-0632-x. Epub 2015 Jan 30.
Arterial stiffness estimated by pulse wave velocity (PWV) is an independent predictor of cardiovascular morbidity and mortality. Although recommended by the current guidelines, clinical applicability of this parameter is difficult, due to differences between the various techniques used to measure it and to biological variability. Our aim was to compare PWV assessed by 3 different commercially available systems. 100 subjects (51 ± 16 years, 45 men) were evaluated using the 3 methods: an oscillometric technique (Arteriograph, PWV-A); a piezo-electric method (Complior, PWV-C); and an high-resolution ultrasound technique implemented with an Echo-tracking system (Aloka, PWV-E). Conventional biological markers were measured. Correlations of PWV measured by the 3 methods were poor (r = 0.39, r = 0.39, and r = 0.31 for PWV-A vs. PWV-C, PWV-A vs. PWV-E, and PWV-C vs. PWV-E, respectively, all p < 0.05). By Bland-Altman analysis, mean difference (±SD) of PWV-A vs. PWV-C was -1.9 ± 2.0 m/s, of PWV-A vs. PWV-E -3.6 ± 1.9 m/s, and of PWV-C vs. PWV-E -2.7 ± 1.9 m/s, with a wide coefficient of variation (22.3, 25.7, and 25.7 %, respectively). As expected, PWV-A, PWV-C, and PWV-E correlated with other arterial stiffness parameters, such as intima-media thickness (r = 0.22, r = 0.22, and r = 0.36, respectively), E p (r = 0.37, r = 0.26, and r = 0.94, respectively), and augmentation index measured by Arteriograph method (r = 0.66, r = 0.35, and r = 0.26, respectively); all p < 0.05. Assessment of PWV is markedly dependent on the technique used to measure it, related to various methods for measuring traveled distance of the arterial wave. Our results suggest the urgent need to establish reference values of PWV for each of these techniques, separately, to be used in routine clinical practice.
通过脉搏波速度(PWV)估算的动脉僵硬度是心血管疾病发病率和死亡率的独立预测指标。尽管目前的指南推荐使用该指标,但由于用于测量它的各种技术之间存在差异以及生物学变异性,该参数在临床中的适用性较差。我们的目的是比较三种不同的市售系统评估的PWV。使用三种方法对100名受试者(年龄51±16岁,男性45名)进行评估:示波技术(动脉硬度计,PWV-A);压电方法(Complior,PWV-C);以及采用回声跟踪系统实施的高分辨率超声技术(阿洛卡,PWV-E)。测量了传统的生物学标志物。三种方法测量的PWV之间的相关性较差(PWV-A与PWV-C、PWV-A与PWV-E、PWV-C与PWV-E的r值分别为0.39、0.39和0.31,均p<0.05)。通过Bland-Altman分析,PWV-A与PWV-C的平均差值(±标准差)为-1.9±2.0 m/s,PWV-A与PWV-E为-3.6±1.9 m/s,PWV-C与PWV-E为-2.7±1.9 m/s,变异系数较大(分别为22.3%、25.7%和25.7%)。正如预期的那样,PWV-A、PWV-C和PWV-E与其他动脉僵硬度参数相关,如内膜中层厚度(分别为r=0.22、r=0.22和r=0.36)、Ep(分别为r=0.37、r=0.26和r=0.94)以及通过动脉硬度计方法测量的增强指数(分别为r=0.66、r=0.35和r=0.26);均p<0.05。PWV的评估明显依赖于用于测量它的技术,这与测量动脉波传播距离的各种方法有关。我们的结果表明迫切需要分别为这些技术中的每一种建立PWV的参考值,以用于常规临床实践。